Cargando…
Comment on “Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis. Clinical Proteomics”
Autores principales: | Behdarvand Dehkordi, Fereshteh, Chehelgerdi, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598925/ https://www.ncbi.nlm.nih.gov/pubmed/37880604 http://dx.doi.org/10.1186/s12014-023-09433-w |
Ejemplares similares
-
Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis
por: Sohaei, Dorsa, et al.
Publicado: (2023) -
Immunoinformatic prediction of potential immunodominant epitopes from cagW in order to investigate protection against Helicobacter pylori infection based on experimental consequences
por: Chehelgerdi, Matin, et al.
Publicado: (2023) -
Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis
por: Stoop, Marcel P., et al.
Publicado: (2010) -
Comment on: Sensitivity and specificity of cerebrospinal fluid glucose measurement by an amperometric glucometer
por: Alkhalifah, Ahmed
Publicado: (2020) -
Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis
por: Liu, Shilian, et al.
Publicado: (2009)